Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial von Lonial, Sagar, Prof, Weiss, Brendan M, Prof, Usmani, Saad Z, Prof, Singhal, Seema, Prof, Chari, Ajai, Prof, Bahlis, Nizar J, Prof, Belch, Andrew, Prof, Krishnan, Amrita, Prof, Vescio, Robert A, Prof, Mateos, Maria Victoria, Prof, Mazumder, Amitabha, Prof, Orlowski, Robert Z, Prof, Sutherland, Heather J, Prof, Bladé, Joan, Prof, Scott, Emma C, Prof, Oriol, Albert, MD, Berdeja, Jesus, MD, Gharibo, Mecide, Prof, Stevens, Don A, MD, LeBlanc, Richard, Prof, Sebag, Michael, Prof, Callander, Natalie, Prof, Jakubowiak, Andrzej, Prof, White, Darrell, Prof, de la Rubia, Javier, Prof, Richardson, Paul G, Prof, Lisby, Steen, MD, Feng, Huaibao, PhD, Uhlar, Clarissa M, PhD, Khan, Imran, MD, Ahmadi, Tahamtan, MD, Voorhees, Peter M, Prof

Volltext

Safety and tolerability of ixazomib, an oral proteasome inhibitor, in combination with lenalidomide and dexamethasone in patients with previously untreated multiple myeloma: an ope... von Kumar, Shaji K, Prof, Berdeja, Jesus G, MD, Niesvizky, Ruben, Prof, Lonial, Sagar, Prof, Laubach, Jacob P, MD, Hamadani, Mehdi, MD, Stewart, A Keith, Prof, Hari, Parameswaran, Prof, Roy, Vivek, MD, Vescio, Robert, MD, Kaufman, Jonathan L, MD, Berg, Deborah, MSN, Liao, Eileen, PhD, Di Bacco, Alessandra, PhD, Estevam, Jose, BSc, Gupta, Neeraj, PhD, Hui, Ai-Min, MD, Rajkumar, Vincent, Prof, Richardson, Paul G, Prof

Volltext

Serum B-cell maturation antigen is elevated in multiple myeloma and correlates with disease status and survival von Sanchez, Eric, Li, Mingjie, Kitto, Alex, Li, Jennifer, Wang, Cathy S., Kirk, Dylan T., Yellin, Ori, Nichols, Cydney M., Dreyer, Marissa P., Ahles, Cameryn P., Robinson, Austin, Madden, Erik, Waterman, Gabriel N., Swift, Regina A., Bonavida, Benjamin, Boccia, Ralph, Vescio, Robert A., Crowley, John, Chen, Haiming, Berenson, James R.

Volltext

Irradiated Bone Marrow Volume is Associated With Hematologic Toxicity in Patients With Multiple Myeloma von Zhang, Samuel C., Kim, Sungjin, Steers, Jennifer, Stiehl, Bradley, Silos, Katrina D., Grigsby, Giana, Oorloff, Maria, Upadhaya, Taman, Vescio, Robert A., Oveisi, David R., Hakimian, Behrooz, Atkins, Katelyn M., Ballas, Leslie K.

Volltext

A Phase I Study to Assess the Safety and Pharmacokinetics of Single-agent Lorvotuzumab Mertansine (IMGN901) in Patients with Relapsed and/or Refractory CD–56-positive Multiple Myel... von Ailawadhi, Sikander, Kelly, Kevin R., Vescio, Robert A., Jagannath, Sundar, Wolf, Jeffrey, Gharibo, Mecide, Sher, Taimur, Bojanini, Leyla, Kirby, Maurice, Chanan-Khan, Asher

Volltext

Efficacy and safety of once-weekly and twice-weekly bortezomib in patients with relapsed systemic AL amyloidosis: results of a phase 1/2 study von Reece, Donna E., Hegenbart, Ute, Sanchorawala, Vaishali, Merlini, Giampaolo, Palladini, Giovanni, Bladé, Joan, Fermand, Jean-Paul, Hassoun, Hani, Heffner, Leonard, Vescio, Robert A., Liu, Kevin, Enny, Christopher, Esseltine, Dixie-Lee, van de Velde, Helgi, Cakana, Andrew, Comenzo, Raymond L.

Volltext

Development of the Histoculture Drug Response Assay (HDRA) von Hoffman, Robert M., Vescio, Robert A.

Volltext

Long-term follow-up from a phase 1/2 study of single-agent bortezomib in relapsed systemic AL amyloidosis von Reece, Donna E., Hegenbart, Ute, Sanchorawala, Vaishali, Merlini, Giampaolo, Palladini, Giovanni, Bladé, Joan, Fermand, Jean-Paul, Hassoun, Hani, Heffner, Leonard, Kukreti, Vishal, Vescio, Robert A., Pei, Lixia, Enny, Christopher, Esseltine, Dixie-Lee, van de Velde, Helgi, Cakana, Andrew, Comenzo, Raymond L.

Volltext

Phase I/II Trial Assessing Bortezomib and Melphalan Combination Therapy for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma von BERENSON, James R, YANG, Hank H, ADAMS, Julian, SCHENKEIN, David, SWIFT, Regina, SADLER, Karen, JARUTIRASARN, Supol G, VESCIO, Robert A, MAPES, Russell, PURNER, Matthew, LEE, Shi-Pyng, WILSON, Joanna, MORRISON, Blake

Volltext

The Proteasome Inhibitor PS-341 Markedly Enhances Sensitivity of Multiple Myeloma Tumor Cells to Chemotherapeutic Agents von MA, Mark H, YANG, Hank H, NEESER, Jason, MIKAIL, Amy, ADAMS, Julian, SJAK-SHIE, Nelida, VESCIO, Robert A, BERENSON, James R, PARKER, Kimberly, MANYAK, Steven, FRIEDMAN, Jeffrey M, ALTAMIRANO, Cibby, WU, Zhi-Qun, BORAD, Mitesh J, FRANTZEN, Malka, ROUSSOS, Evanthia

Volltext

Weekly and twice-weekly bortezomib in patients with systemic AL amyloidosis: results of a phase 1 dose-escalation study von Reece, Donna E., Sanchorawala, Vaishali, Hegenbart, Ute, Merlini, Giampaolo, Palladini, Giovanni, Fermand, Jean-Paul, Vescio, Robert A., Liu, Xiangyang, Elsayed, Yusri A., Cakana, Andrew, Comenzo, Raymond L.

Volltext

Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution von DOUEK, D. C, VESCIO, R. A, BETTS, M. R, BRENCHLEY, J. M, HILL, B. J, LAN ZHANG, BERENSON, J. R, COLLINS, R. H, KOUP, R. A

Volltext

Safety of bloodless autologous stem cell transplantation in Jehovah's Witness patients von Beck, Alyssa, Lin, Robert, Reza Rejali, Ali, Rubens, Muni, Paquette, Ronald, Vescio, Robert, Merin, Noah, Guerrero, Margarita, Federizo, Yvette, Lua, Michelle, Uy, Leticia, Hernandez, Lorraine, Allred, Mohana, Legaspi, Ronald, Leaverton, Melissa, Oliva, Sara, Castillo, Rhona, Dean, Lorna, Bourke, Jennifer, Cooper, Sara, Gharapetian, Seda, Causin, Jose, Lopiccolo, Christopher, Ann Snoussi, Laura, VanStrien, Patricia, Lill, Michael, Linhares, Yuliya P.

Volltext

Low booster uptake in cancer patients despite health benefits von Figueiredo, Jane C., Levy, Julia, Choi, So Yung, Xu, Alexander M., Merin, Noah M., Hamid, Omid, Lemos, Tucker, Nguyen, Nathalie, Nadri, Maimoona, Gonzalez, Alma, Mahov, Simeon, Darrah, Justin M., Gong, Jun, Paquette, Ronald L., Mita, Alain C., Vescio, Robert A., Salvy, Sarah J., Mehmi, Inderjit, Hendifar, Andrew E., Natale, Ronald, Tourtellotte, Warren G., Ramanujan, V. Krishnan, Huynh, Carissa A., Sobhani, Kimia, Reckamp, Karen L., Merchant, Akil A.

Volltext

An open‐label, phase 2 trial of denosumab in the treatment of relapsed or plateau‐phase multiple myeloma von Vij, Ravi, Horvath, Noemi, Spencer, Andrew, Taylor, Kerry, Vadhan‐Raj, Saroj, Vescio, Robert, Smith, Judy, Qian, Yi, Yeh, Howard, Jun, Susie

Volltext

Overcoming Drug Resistance in Multiple Myeloma: The Emergence of Therapeutic Approaches to Induce Apoptosis von YANG, Hank H, MA, Mark H, VESCIO, Robert A, BERENSON, James R

Volltext

Optimizing Care: Discontinuing Medications Prior to Daratumumab and Hyaluronidase-Fihj Subcutaneous Injection (OMIT) von Yudchyts, Anya, Lin, Tiffany, Vescio, Robert

Volltext

Tirapazamine Plus Cisplatin Versus Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Report of the International CATAPULT I Study Group von VON PAWEL, J, VON ROEMELING, R, OLVER, I, BERGMAN, B, AYOUB, J, RICHARDSON, G, DUNLOP, D, ARCENAS, A, VESCIO, R, VIALLET, J, TREAT, J, GATZEMEIER, U, BOYER, M, ELISSON, L. O, CLARK, P, TALBOT, D, REY, A, BUTLER, T. W, HIRSH, V

Volltext

Purging of Autologous Peripheral-Blood Stem Cells Using CD34 Selection Does Not Improve Overall or Progression-Free Survival After High-Dose Chemotherapy for Multiple Myeloma: Resu... von STEWART, A. Keith, VESCIO, Robert, STIFF, Pat, MEHARCHARD, Jacinta, SCHLOSSMAN, Robert, BROWN, Randy, TULLY, Heather, BENYUNES, Mark, JACOBS, Cindy, BERENSON, Ronald, WHITE, Michael, DIPERSIO, John, SCHILLER, Gary, ANDERSON, Kenneth C, BERENSON, James, BALLESTER, Oscar, NOGA, Stephen, RUGO, Hope, FREYTES, Cesar, STADTMAUER, Edward, TARANTOLO, Stefano, SAHEBI, Firoozeh

Volltext

A Phase I Dose-ranging Trial of Monthly Infusions of Zoledronic Acid for the Treatment of Osteolytic Bone Metastases von BERENSON, James R, VESCIO, Robert A, LIPTON, Allan, ROSEN, Lee S, VONTEICHERT, Joseph M, WOO, Margie, SWIFT, Regina, SAVAGE, Allison, GIVANT, Elise, HUPKES, Mieke, HARVEY, Harold

Volltext